ByTrending Posts
Can VUMC’s New AI Technologies Reshape Cancer Diagnostics…
Key Highlights AI-Powered MSI-SEER Revolutionizes Tumor ProfilingVanderbilt University Medical Center (VUMC), in collaboration with Mayo Clinic and leading…
How Carterra, Pfizer, and GSK Are Scaling AI…
Key Highlights AI at the Core of the Next Drug Discovery WaveCarterra Inc., a front-runner in high-throughput biology,…
How Is Caltech’s AI Smart Bandage Set to…
Key Highlights Smart Bandage Breakthrough: A Strategic AI-Driven Platform from CaltechIn a landmark step toward intelligent wound management,…
Can Bayer’s Partnership with Altis Labs’ AI Boost…
Altis’ IPRO-Δ AI model outperforms RECIST in predicting survival, signaling a major shift in oncology trial endpoint Altis-Bayer…
Is IBM and Inclusive Brains’ AI-Quantum Fusion the…
Key Highlights Advancing Accessibility Through Multimodal AI and Brain-Machine InterfacesThe collaboration aims to improve the classification accuracy of…
AI at the FDA: Will ‘Elsa’ Redefine How…
Key highlights Regulatory AI Disruption: Why the FDA’s ‘Elsa’ Tool Is a Gamechanger for Biopharma The U.S. Food…
AI in Pharmacovigilance: Why Are Top Global Biopharma…
Key Highlights Industry Confidence Grows as NavaX Gains MomentumArisGlobal, a leader in life sciences technology, has announced the…
Can the FDA’s Elsa AI Transform Medical Device…
Key Takeaways Transforming the FDA’s Mission With Secure Generative AIIn a landmark step toward modernizing regulatory science, the…
Will Sanofi’s $9.5B Acquisition of Blueprint Redefine the…
Key Takeaways for Biopharma Executives Strategic Expansion: Sanofi Bets Big on Rare Immunology and US Biotech InnovationIn a…
Trending Posts
Latest Stories
What Does SoftBank’s $41 Billion Bet on OpenAI Signal for the Future of Biopharma, Healthcare, and AI Infrastructure?
Global – December 2025 — SoftBank’s $41 billion investment in OpenAI represents one of the…
Did Ophthalmic Therapy Approvals in 2025 Redefine Vision Care—and Set the Stage for Accelerated Innovation in 2026?
Global – December 2025 — The ophthalmology therapeutic area entered a renewed phase of innovation…
Did Metabolic Therapy Approvals in 2025 Reset the Standard of Care—and Ignite a New Growth Cycle in 2026?
Global – December 2025 — The metabolic therapeutic area emerged as one of the most…
Did Renal Therapy Approvals in 2025 Redefine Kidney Disease Management—and Set the Stage for Breakthroughs in 2026?
Global – December 2025 — The renal therapeutic area emerged as a renewed focus of…
Gallery
